About Am Thyrovision Laboratories Private Limited
Data last updated:
Am Thyrovision Laboratories Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the preventive healthcare segment of the healthcare sector. It was incorporated on 06 December 2005 and has been in existence for over 21 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U85195DL2005PTC143352.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹2.75 Lakh. It is led by directors Satya Pal Gupta and Anju Mishra.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at F – 126 Lower Ground Floor Village Katwaria Sarai, New Delhi, Delhi, India – 110016.
As per the financials filed for FY 2025, the company reported a revenue of ₹7.13 Cr, a growth of 20% compared to the previous year. For the same year it recorded a net profit of ₹11.14 Lakh (net margin 1.6%) and EBITDA of ₹31.05 Lakh (EBITDA margin 4.4%). Revenue has grown at a compounded annual rate (CAGR) of 39% over three years and 25% over five years.
The company has about 7 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹45 Lakh and satisfied charges of ₹8.5 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website thyrovision.org.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressF – 126 Lower Ground Floor Village Katwaria Sarai, New Delhi, Delhi, India – 110016
- IndustryHealthcare, Preventive Health Services
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Am Thyrovision Laboratories Private Limited
The main business activity of Am Thyrovision Laboratories is human health and social work activities. In detail, this covers human health activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Q | Human health and social work activities | 86 | Human health activities | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Am Thyrovision Laboratories Private Limited FY 2025 filings available
Am Thyrovision Laboratories Private Limited reported revenue of ₹7.13 Cr (up 20% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Am Thyrovision Laboratories Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 25% over five years, including 20% growth in the latest year. EBITDA rose 37% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Am Thyrovision Laboratories Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹31.05 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹11.14 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Am Thyrovision Laboratories Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.4% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 1.6% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Am Thyrovision Laboratories are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Am Thyrovision Laboratories Private Limited
Am Thyrovision Laboratories Private Limited is compared with the companies closest to it by revenue in the Healthcare industry (Diagnostics and Pathology Labs). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| SRG Healthcare Private Limited | ₹7.18 Cr (FY 2025) | •••• | •••• | 1.0% | •••• | Davangere., Karnataka, India |
| Grayscale Intervention & Diagnostics Center Private Limited | ₹7.17 Cr (FY 2025) | •••• | •••• | 1.0% | •••• | Jaipur, Rajasthan, India |
| KDC Lab Private Limited | ₹7.17 Cr (FY 2025) | •••• | •••• | 251.0% | •••• | Hosdurg, Kerala, India |
| Novo Healthcare Limited | ₹7.17 Cr (FY 2025) | •••• | •••• | 41.0% | •••• | New Delhi, Delhi, India |
| Paramountcy Research and Diagnostic Centre Private Limited | ₹7.15 Cr (FY 2024) | •••• | •••• | -5.0% | •••• | Thiruvananthapuram, Kerala, India |
| Am Thyrovision Laboratories Private Limited this company | ₹7.13 Cr (FY 2025) | •••• | •••• | 20.0% | •••• | New Delhi, Delhi, India |
| KJR Genetics Private Limited | ₹7.12 Cr (FY 2025) | •••• | •••• | -2.0% | •••• | Kolkata, West Bengal, India |
| Bandhan Life Science Private Limited | ₹7.12 Cr (FY 2025) | •••• | •••• | 1.0% | •••• | Kolkata, West Bengal, India |
| Medix Diagnostics & Mri Centre Private Limited | ₹7.09 Cr (FY 2025) | •••• | •••• | 3.0% | •••• | New Delhi, Delhi, India |
| Shivaparvathi Medical Services Private Limited | ₹7.08 Cr (FY 2024) | •••• | •••• | 41.0% | •••• | Bellary, Karnataka, India |
| Raman Imaging and Diagnostic Private Limited | ₹7.03 Cr (FY 2025) | •••• | •••• | 25.0% | •••• | Patna, Bihar, India |
Peers are the five companies nearest above and the five nearest below Am Thyrovision Laboratories by revenue in the Healthcare industry (Diagnostics and Pathology Labs), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Am Thyrovision Laboratories Private Limited
Am Thyrovision Laboratories Private Limited is audited by K C MISHRA & CO. for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| K C MISHRA & CO. | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Am Thyrovision Laboratories Private Limited
Am Thyrovision Laboratories has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Satya Pal Gupta | Director | 06 Dec 2005 | 20 Years 10 Months | Current |
| Anju Mishra | Director | 06 Dec 2005 | 20 Years 10 Months | Current |
Ownership and Shareholding of Am Thyrovision Laboratories Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Am Thyrovision Laboratories Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 02 Jan 2021 | Hdfc Bank Limited | ₹45 Lakh | Open |
| 22 May 2012 | Siemens Financial Services Private Limited | ₹8.5 Lakh | Satisfied |
Total charge records: 2 View all charges
MSME Payment Delays by Am Thyrovision Laboratories Private Limited
Am Thyrovision Laboratories Private Limited has 9 MSME Form 1 returns on record between 2019 and 2023, listing 37 overdue payments to 7 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 7)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Embee Diagnostics Private Limited | •••• | •••• | •••• |
| Biocem Solutions | •••• | •••• | •••• |
| Immuno Diagnostics Pvt Ltd | •••• | •••• | •••• |
| Dr Meditech Surgical and Diagnostics (India) Private Limited | •••• | •••• | •••• |
| Biologic | •••• | •••• | •••• |
Full MSME payment history
Every supplier, amount and due date from all 9 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Employees and EPFO Compliance at Am Thyrovision Laboratories Private Limited
Am Thyrovision Laboratories Private Limited has a workforce of 7 employees as of Apr 05, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Am Thyrovision Laboratories Private Limited
Am Thyrovision Laboratories Private Limited has 4 board changes on record since 2005: 3 appointments and 1 cessation. The latest: Ranjit Singh ceased to be Additional Director on 26 Sep 2022.
Credit Ratings, Litigation & Regulatory Alerts for Am Thyrovision Laboratories Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Am Thyrovision Laboratories Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Am Thyrovision Laboratories Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Am Thyrovision Laboratories Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Am Thyrovision Laboratories Private Limited
Am Thyrovision Laboratories is an active private limited company based in New Delhi, Delhi, India. The company works in preventive health services, within the healthcare industry. It was incorporated on 06 December 2005 (21+ years old) and is registered under CIN U85195DL2005PTC143352.
Am Thyrovision Laboratories reported revenue of ₹7.13 Cr for FY 2025 (up 20% YoY).
Am Thyrovision Laboratories has 2 current directors:
- Satya Pal Gupta - Director
- Anju Mishra - Director
Am Thyrovision Laboratories reported a net profit of ₹11.14 Lakh (net margin 1.6%) and EBITDA of ₹31.05 Lakh (EBITDA margin 4.4%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Am Thyrovision Laboratories is 39% over three years and 25% over five years. In the latest year (FY 2025) revenue rose 20%. CAGR is the steady yearly rate that links the first and the last year.
The CIN (Corporate Identification Number) of Am Thyrovision Laboratories is U85195DL2005PTC143352. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Am Thyrovision Laboratories was incorporated on 06 December 2005, making it 21+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Am Thyrovision Laboratories by revenue are SRG Healthcare Private Limited, Grayscale Intervention & Diagnostics Center Private Limited, KDC Lab Private Limited, Novo Healthcare Limited, Paramountcy Research and Diagnostic Centre Private Limited and 5 more, all in the Healthcare industry (Diagnostics and Pathology Labs).
Ranjit Singh ceased to be Additional Director on 26 Sep 2022. Ranjit Singh was appointed as Additional Director on 08 Mar 2021. Anju Mishra was appointed as Director on 06 Dec 2005. Am Thyrovision Laboratories has 4 board changes on record in total.
Am Thyrovision Laboratories has 9 MSME Form 1 returns on record between 2019 and 2023, listing 37 overdue payments to 7 micro and small suppliers. The latest return was filed on 21 Nov 2023.
Am Thyrovision Laboratories can be reached through the website thyrovision.org. Its registered office is in New Delhi, Delhi, India.
The registered office of Am Thyrovision Laboratories is at F – 126 Lower Ground Floor Village Katwaria Sarai, New Delhi, Delhi, India – 110016.